Steven Cohen’s Organon & Co OGN Stock Holding History

Steven Cohen’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-238,000	Closed	-$1.43M	–	4431
2026 Q1	$1.43M	Sell	238,000 -417,731	-64%	-$3.14M	﹤0.01%	2534
2025 Q4	$4.7M	Buy	+655,731	New	+$5.18M	0.01%	1896
2024 Q1	–	Sell	-3,188,800	Closed	-$46M	–	2498
2023 Q4	$46M	Buy	3,188,800 +3,179,778	+35,245%	+$43.3M	0.11%	233
2023 Q3	$157K	Buy	+9,022	New	+$188K	﹤0.01%	1828
2023 Q2	–	Sell	-35,260	Closed	-$829K	–	2600
2023 Q1	$829K	Buy	+35,260	New	+$947K	﹤0.01%	1134

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Steven Cohen's OGN Position: Q2 2026 in Review

Steven Cohen sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 238,000 shares — an estimated $1.43M sold.

Steven Cohen first reported a position in OGN in Q1 2023 and held it in 5 quarters. The position peaked at $46M in Q4 2023. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Steven Cohen reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 238,000 Organon & Co shares in Q2 2026, an estimated $1.43M.
Steven Cohen first reported a position in Organon & Co in Q1 2023 and held it in 5 quarters.
Steven Cohen's Organon & Co position peaked at $46M in Q4 2023.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.